Sturla Grøndal

Researcher

Current role and affiliations

Sturla Magnus Grøndal holds a Bachelor’s degree in Nanotechnology and a Master’s degree in Nanoscience from the University of Bergen. He began his PhD at the Department of Biomedicine in summer 2020, supervised by James Lorens with Silke Appel as co-supervisor, and completed it in 2024.

In 2025, he was awarded a postdoctoral fellowship from Helse Vest to study biomarkers of response to bemcentinib in cancer patients. 

He is currently affiliated with the K.G. Jebsen Center for Myeloid Blood Cancer (CMYC) under the supervision of Bjørn Tore Gjertsen.

Selected publications 

  • Targeting AXL cellular networks in kidney fibrosis
    Sturla M Grøndal, Magnus Blø, Linn I H Nilsson, Austin J Rayford, Akil Jackson, Gro Gausdal, James B Lorens
    Front Immunol. 2024 Nov 4:15:1446672. doi: 10.3389/fimmu.2024.1446672. eCollection 2024.
  • Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH
    Sturla Magnus Grøndal, Anna Tutusaus, Loreto Boix, Maria Reig, Magnus Blø, Linn Hodneland, Gro Gausdal, Akil Jackson, Pablo Garcia de Frutos, James Bradley Lorens, Albert Morales, Montserrat Marí
    Front Immunol. 2024 May 16:15:1400553. doi: 10.3389/fimmu.2024.1400553. eCollection 2024.
Published Mar. 18, 2024 11:25 AM - Last modified May 15, 2026 1:11 PM